晚期黄斑变性患者的焦虑与抑郁：当前观点
Anxiety and depression in patients with advanced macular degeneration: current perspectives.
作者信息
Cimarolli Verena R, Casten Robin J, Rovner Barry W, Heyl Vera, Sörensen Silvia, Horowitz Amy
机构信息
Research Institute on Aging, Jewish Home Lifecare, New York, NY, USA.
Department of Psychiatry and Human Behavior, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.
出版信息
Clin Ophthalmol. 2015 Dec 30;10:55-63. doi: 10.2147/OPTH.S80489. eCollection 2016.
Abstract
Age-related macular degeneration (AMD) - despite advances in prevention and medical treatment options - remains prevalent among older adults, often resulting in functional losses that negatively affect the mental health of older adults. In particular, the prevalence of both anxiety and depression in patients with AMD is high. Along with medical treatment options, low vision rehabilitation and AMD-specific behavioral and self-management programs have been developed and have demonstrated effectiveness in improving the mental health of AMD patients. This article reviews the prevalence of anxiety and depression in patients with advanced AMD, discusses potential mechanisms accounting for the development of depression and anxiety in AMD patients, presents the state-of the-art of available interventions for addressing anxiety and depression in AMD patients, and delineates recommendations for eye care professionals regarding how to screen for these two prevalent mental health problems and how to facilitate appropriate treatment for patients with AMD.
摘要
年龄相关性黄斑变性（AMD）——尽管在预防和治疗选择方面取得了进展——在老年人中仍然很普遍，常常导致功能丧失，对老年人的心理健康产生负面影响。特别是，AMD患者中焦虑和抑郁的患病率都很高。除了治疗选择外，低视力康复以及针对AMD的行为和自我管理项目已经得到开发，并已证明在改善AMD患者的心理健康方面有效。本文综述了晚期AMD患者中焦虑和抑郁的患病率，讨论了导致AMD患者发生抑郁和焦虑的潜在机制，介绍了针对AMD患者焦虑和抑郁的现有干预措施的现状，并就如何筛查这两种常见的心理健康问题以及如何促进AMD患者的适当治疗向眼科护理专业人员提出了建议。
相似文献
1
Anxiety and depression in patients with advanced macular degeneration: current perspectives.晚期黄斑变性患者的焦虑与抑郁：当前观点
Clin Ophthalmol. 2015 Dec 30;10:55-63. doi: 10.2147/OPTH.S80489. eCollection 2016.
2
Psychological and Psychosocial Interventions for Depression and Anxiety in Patients With Age-Related Macular Degeneration: A Systematic Review.年龄相关性黄斑变性患者抑郁和焦虑的心理和心理社会干预：系统评价。
Am J Geriatr Psychiatry. 2019 Aug;27(8):755-773. doi: 10.1016/j.jagp.2019.03.001. Epub 2019 Mar 7.
3
Prevention and treatment of age-related macular degeneration: an update for pharmacists.年龄相关性黄斑变性的预防与治疗：药剂师须知的最新进展
Consult Pharm. 2013 Nov;28(11):723-37. doi: 10.4140/TCP.n.2013.723.
4
Update on depression and age-related macular degeneration.抑郁症与年龄相关性黄斑变性的最新研究进展。
Curr Opin Ophthalmol. 2013 May;24(3):239-43. doi: 10.1097/ICU.0b013e32835f8e55.
5
Psychosocial effects of age-related macular degeneration.年龄相关性黄斑变性的社会心理影响。
Int Psychogeriatr. 2006 Sep;18(3):415-28. doi: 10.1017/S1041610205002905. Epub 2006 Feb 8.
6
Prevalence of Undiagnosed Age-Related Macular Degeneration in Primary Eye Care.初级眼科保健中未诊断出的年龄相关性黄斑变性的患病率
JAMA Ophthalmol. 2017 Jun 1;135(6):570-575. doi: 10.1001/jamaophthalmol.2017.0830.
7
Age related macular degeneration and visual disability.年龄相关性黄斑变性与视力障碍。
Curr Drug Targets. 2011 Feb;12(2):221-33. doi: 10.2174/138945011794182755.
8
Prevalence of depression, anxiety, adjustment disorders, and somatoform disorders in patients with age-related macular degeneration in Germany.德国年龄相关性黄斑变性患者中抑郁症、焦虑症、适应障碍和躯体形式障碍的患病率。
Ger Med Sci. 2017 Feb 9;15:Doc04. doi: 10.3205/000245. eCollection 2017.
9
The incidence and predictors of depressive and anxiety symptoms in older adults with vision impairment: a longitudinal prospective cohort study.视力受损老年人抑郁和焦虑症状的发生率及预测因素：一项纵向前瞻性队列研究。
Ophthalmic Physiol Opt. 2017 Jul;37(4):385-398. doi: 10.1111/opo.12388. Epub 2017 May 18.
10
[Humanistic burden and health resource utilization among neovascular age-related macular degeneration patients in France].[法国新生血管性年龄相关性黄斑变性患者的人文负担与卫生资源利用情况]
J Fr Ophtalmol. 2008 Feb;31(2):138-45. doi: 10.1016/s0181-5512(08)70346-2.
引用本文的文献
1
Geographic atrophy and factors associated with disease progression among Medicare Advantage enrollees.医疗保险优势参保者中的地理性萎缩及与疾病进展相关的因素。
J Manag Care Spec Pharm. 2025 Jan;31(1):42-52. doi: 10.18553/jmcp.2025.31.1.42.
2
Potential Structural Biomarkers in 3D Images Validated by the First Functional Biomarker for Early Age-Related Macular Degeneration - ALSTAR2 Baseline.经早期年龄相关性黄斑变性的首个功能生物标志物（ALSTAR2 基线）验证的 3D 图像中的潜在结构生物标志物。
Invest Ophthalmol Vis Sci. 2024 Feb 1;65(2):1. doi: 10.1167/iovs.65.2.1.
3
Use of the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) questionnaires for clinical decision-making and psychological referral in ophthalmic care: a multicentre observational study.使用患者健康问卷-9（PHQ-9）和广泛性焦虑障碍-7（GAD-7）问卷进行眼科护理的临床决策和心理转诊：一项多中心观察性研究。
BMJ Open. 2024 Jan 18;14(1):e075141. doi: 10.1136/bmjopen-2023-075141.
4
Disease Awareness Among Patients With Age-Related Macular Degeneration: Patterns and Predictors.年龄相关性黄斑变性患者的疾病认知：模式与预测因素
J Vitreoretin Dis. 2023 Dec 14;8(1):58-66. doi: 10.1177/24741264231210078. eCollection 2024 Jan-Feb.
5
One-year outcomes of resveratrol supplement with aflibercept versus aflibercept monotherapy in wet age-related macular degeneration.白藜芦醇联合阿柏西普与阿柏西普单药治疗湿性年龄相关性黄斑变性的一年疗效
Int J Ophthalmol. 2023 Sep 18;16(9):1496-1502. doi: 10.18240/ijo.2023.09.17. eCollection 2023.
6
FITC-Labeled RGD Peptides as Novel Contrast Agents for Functional Fluorescent Angiographic Detection of Retinal and Choroidal Neovascularization.荧光素标记的 RGD 肽作为新型对比剂，用于视网膜和脉络膜新生血管的功能荧光血管造影检测。
Cells. 2023 Jul 21;12(14):1902. doi: 10.3390/cells12141902.
7
Three-Month Safety and Efficacy Outcomes for the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT™).新一代小切口可植入微型望远镜（SING IMT™）的三个月安全性和有效性结果。
J Clin Med. 2023 Jan 8;12(2):518. doi: 10.3390/jcm12020518.
8
The impact of COVID-19 on the everyday life of blind and sighted individuals.新型冠状病毒肺炎对盲人和有视力者日常生活的影响。
Front Psychol. 2022 Oct 28;13:897098. doi: 10.3389/fpsyg.2022.897098. eCollection 2022.
9
Mental health and visual acuity in patients with age-related macular degeneration.年龄相关性黄斑变性患者的心理健康和视力。
BMC Ophthalmol. 2022 Oct 2;22(1):391. doi: 10.1186/s12886-022-02602-9.
10
Patient Preferences in the Management of Wet Age-Related Macular Degeneration: A Conjoint Analysis.患者对湿性年龄相关性黄斑变性治疗选择的偏好：联合分析。
Adv Ther. 2022 Oct;39(10):4808-4820. doi: 10.1007/s12325-022-02248-5. Epub 2022 Aug 22.
本文引用的文献
1
Help seeking among vision-impaired adults referred to their GP for depressive symptoms: patient characteristics and outcomes associated with referral uptake.因抑郁症状被转诊至全科医生处的视力受损成年人的求助行为：与转诊接受情况相关的患者特征及结果
Aust J Prim Health. 2015;21(2):169-75. doi: 10.1071/py13085.
2
High Prevalence of Untreated Depression in Patients Accessing Low-Vision Services.在接受低视力服务的患者中，未经治疗的抑郁症患病率很高。
Ophthalmology. 2016 Feb;123(2):440-441. doi: 10.1016/j.ophtha.2015.07.009. Epub 2015 Aug 13.
3
Watchful waiting for subthreshold depression and anxiety in visually impaired older adults.对视障老年人阈下抑郁和焦虑进行观察等待。
Qual Life Res. 2015 Dec;24(12):2885-93. doi: 10.1007/s11136-015-1032-5. Epub 2015 Jun 18.
4
The macular degeneration and aging study: Design and research protocol of a randomized trial for a psychosocial intervention with macular degeneration patients.黄斑变性与衰老研究：一项针对黄斑变性患者的社会心理干预随机试验的设计与研究方案
Contemp Clin Trials. 2015 May;42:68-77. doi: 10.1016/j.cct.2015.03.007. Epub 2015 Mar 24.
5
Do problem-solving interventions improve psychosocial outcomes in vision impaired adults: a systematic review and meta-analysis.解决问题干预措施能否改善视力受损成年人的心理社会结局：一项系统评价与荟萃分析
Patient Educ Couns. 2015 May;98(5):553-64. doi: 10.1016/j.pec.2015.01.013. Epub 2015 Jan 27.
6
Major depressive and anxiety disorders in visually impaired older adults.视障老年人的重度抑郁和焦虑障碍。
Invest Ophthalmol Vis Sci. 2015 Jan 20;56(2):849-54. doi: 10.1167/iovs.14-15848.
7
A randomised controlled trial of a self-management programme for low vision implemented in low vision rehabilitation services.一项在低视力康复服务中实施的低视力自我管理计划的随机对照试验。
Patient Educ Couns. 2015 Feb;98(2):174-81. doi: 10.1016/j.pec.2014.11.008. Epub 2014 Nov 20.
8
Why visually impaired older adults often do not receive mental health services: the patient's perspective.视障老年人为何常常无法获得心理健康服务：患者视角
Qual Life Res. 2015 Apr;24(4):969-78. doi: 10.1007/s11136-014-0835-0. Epub 2014 Nov 15.
9
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.全球与年龄相关的黄斑变性患病率及 2020 与 2040 年疾病负担预测：系统回顾和荟萃分析。
Lancet Glob Health. 2014 Feb;2(2):e106-16. doi: 10.1016/S2214-109X(13)70145-1. Epub 2014 Jan 3.
10
Effectiveness of rehabilitation interventions in improving emotional and functional status in hearing or visually impaired older adults: a systematic review with meta-analyses.康复干预对改善听力或视力受损老年人情绪和功能状态的有效性：一项荟萃分析的系统评价
Clin Rehabil. 2015 Feb;29(2):107-19. doi: 10.1177/0269215514542639. Epub 2014 Jul 15.
Zotero 插件